Form 4 for ALZN Alzamend Neuro, Inc.
Accepted 2024-01-25 00:00:00 ET · period of report 2024-01-23 · accession 0001214659-24-001199 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-01-25 | 2024-01-23 | ALZN | AULT MILTON C III | Dir, 10% | J - Other | $0.00 | -661.2K | 5,498 | -99% | $0 |
| DI | 2024-01-25 | 2024-01-23 | ALZN | AULT MILTON C III | Dir, 10% | J - Other | $0.00 | -666.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-23 | J | D | 661,168 | $0.00 | 5,498 | I By Ault Life Sciences Fund, LLC | — | — | (F1) These shares, which were pledged as security for the repayment of a promissory note owed by Ault Life Sciences Fund, LLC ("ALSF"), were returned to the Issuer as part of a settlement agreement between the Issuer and ALSF (the "Settlement Agreement"), whereby the outstanding obligation, among other rights, were terminated. (F2) Mr. Ault has sole voting and investment power with respect to the securities held of record by ALSF. |
| 2 | Derivative | Warrants | 2024-01-23 | J | D | 666,666 | $0.00 | 0 | I By Ault Life Sciences Fund, LLC | $45.00 · 2019-04-30 to 2024-04-29 | 666,666 Common Stock | (F2) Mr. Ault has sole voting and investment power with respect to the securities held of record by ALSF. |